MarketCap
Amarin Corporation plc AMRN
€ 10.33
-0.09%
Facebook
X
Telegram
Amarin Corporation plc Operativer Cashflow | AMRN
Operativer Cashflow Jährlich Amarin Corporation plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.73 M | -31 M | 6.88 M | -180 M | -66.5 M | -21.7 M | -9.37 M | -94.7 M | -32.8 M | -71.8 M | - | - | -190 M | -122 M | -39.4 M | -33.9 M | -28.4 M | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.88 M | -190 M | -60.6 M |
Operativer Cashflow Vierteljährlich Amarin Corporation plc
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 6.6 M | 6.39 M | 15.3 M | -12.7 M | 16.6 M | -12.5 M | -13.3 M | -2.36 M | -2.75 M | -12.6 M | -645 K | 7.33 M | 7.2 M | -7.01 M | 1.55 M | -18.2 M | -64.6 M | -98.8 M | -28.2 M | -4.54 M | -15.1 M | -18.7 M | -38.3 M | 10.9 M | 1.59 M | 4.14 M | -8.94 M | 21.8 M | 15.9 M | -38.1 M | -32.3 M | -28.2 M | -24.4 M | -9.8 M | -2.14 M | -6.28 M | -24.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | -33.1 M | -44.8 M | -52.8 M | -59.6 M | -43.8 M | -39.4 M | -21.4 M | -17.7 M | -11.6 M | -8.28 M | -19.6 M | -8.81 M |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.8 M | -98.8 M | -15.7 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
KalVista Pharmaceuticals
KALV
|
-81.6 M | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
-1.6 M | - | -0.34 % | $ 200 M |  USA |
 |
Kezar Life Sciences
KZR
|
-51.8 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
-3.07 M | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-129 M | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
-8.43 M | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-15.7 M | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
-22.2 M | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
-18.2 M | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
-159 M | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-138 M | $ 8.55 | -8.85 % | $ 593 M | USA |
 |
BiomX
PHGE
|
-26.4 M | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-25 M | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-20.8 M | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-19.6 M | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-6.95 M | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-2.37 M | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
-32.3 M | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-73.9 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-97.2 M | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-4.83 M | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-20.5 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-12.8 M | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-16.7 M | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-4.36 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-15.6 M | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-10.2 M | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
-2.05 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
2.87 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-76.4 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
-59.9 M | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-15.4 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
109 M | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-83.5 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-9.12 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-13.5 M | - | - | $ 13 M | USA |
 |
Lyra Therapeutics
LYRA
|
-28.9 M | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-84.3 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-22.7 M | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
-88.6 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-24.7 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-186 M | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-83.3 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-186 M | $ 4.21 | 4.99 % | $ 653 M | USA |
 |
AbbVie
ABBV
|
19 B | $ 291.22 | 1.06 % | $ 515 B | USA |